CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.
Media Contact: [email protected]
Three new startups to participate in the Kansai Life Science Accelerator Program 2022
Aug 8, 2022
August 8, 2022 Kansai Life Science Accelerator Program (KLSAP), launched in 2020, is co-hosted by the City of Kobe, Foundation for Biomedical Research and Innovation at Kobe (FBRI), Bayer Yakuhin,..
Read MoreCongressional Efforts on Prescription Drugs Imperil Patients and Life Sciences Innovation in California
Aug 5, 2022
Until recently, there was no treatment for lung cancer patients with the aggressive KRAS G12C mutation, one of the most prevalent drivers of lung cancer. The mutation was considered “undruggable”..
Read MoreOPEN LETTER: 31 biopharmaceutical CEOs urge Congress to protect the life sciences industry
Aug 4, 2022
August 4, 2022 California Representatives and Senators U.S. Congress Washington, DC We write as the leadership of small and emerging biopharmaceutical companies in California that represent the leading edge of..
Read MoreLife sciences leaders to explore industry’s role in achieving Cancer Moonshot
Aug 3, 2022
FOR IMMEDIATE RELEASE: August 3, 2022 NEWPORT BEACH, Calif. – California Life Sciences, the state’s most influential life sciences membership organization, will be hosting the annual event, “An Evening..
Read MoreCalifornia Life Sciences sponsors 12 high school students to participate in STEM program
Aug 2, 2022
August 2, 2022 ORANGE COUNTY, Calif. – California Life Sciences (CLS), the state’s most impactful life sciences membership organization, has committed $36,000 to sponsor 12 high school girls of color..
Read MoreCLS joins the Council of State Bioscience Associations to express concerns about drug pricing proposals
Jul 20, 2022
July 20, 2022 Dear Senate Majority Leader Schumer, Senate Republican Leader McConnell, House Speaker Pelosi, and House Republican Leader McCarthy: The Council of State Bioscience Associations (CSBA) is an alliance..
Read More